Acorda Therapeutics, Inc. (NASDAQ:ACOR)

Headlines for Acorda Therapeutics, Inc.

Acorda Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
StreetInsider.com - Nov 16, 2009
HAWTHORNE, NY--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, MD, President & CEO, will present at the upcoming Lazard Capital Markets 6th Annual ...
New Report Just Published Acorda Therapeutics Inc - Detailed Product Pipeline
Live-PR.com - Nov 11, 2009
(live-PR.com) - Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue. contain detailed information on pipelines by ...
Continued Growth At Centron With New Assignments From Cephalon And Acorda Therapeutics
PharmaLive - Nov 10, 2009
NEW YORK – November 10 – Centron, a medical communications company, is pleased to announce that they have been awarded the agency of record assignment for AMRIX® (Cyclobenzaprine Hydrochloride ...
Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and Acorda Therapeutics
Business Wire - Nov 10, 2009
CHICAGO--(BUSINESS WIRE)--Zacks.com releases the latest Industry Outlook. Today, Zacks Equity Research discusses the Big Pharma & Biotech Industry, including Alcon (NYSE: ACL), Novartis (NYSE: NVS ...
Big Pharma And Biotech - Industry Outlook
istockAnalyst.com - Nov 9, 2009
The pharmaceutical industry has witnessed major changes in 2009. Performance has been affected by factors like sluggish prescription trends, intensifying generic competition and limited phase III ...